SG Americas Securities
SER icon

SG Americas Securities’s Serina Therapeutics SER Stock Holding History

SG Americas Securities’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-363
Closed -$12K – 3545
2020
Q2 		$12K Buy
+363
New +$10.7K ﹤0.01% 3626
2019
Q2 		– Sell
-309
Closed -$44K – 3483
2019
Q1 		$44K Sell
309
-83
-21% -$12.1K ﹤0.01% 3215
2018
Q4 		$41K Buy
+392
New +$49.8K ﹤0.01% 2845

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

SG Americas Securities's SER Position: Q3 2020 in Review

SG Americas Securities sold out of Serina Therapeutics (SER) in Q3 2020, closing a stake of 363 shares — an estimated $12K sold.

SG Americas Securities first reported a position in SER in Q4 2018 and held it in 3 quarters. The position peaked at $44K in Q1 2019. 36 funds tracked by Wall St. Rank hold SER as of Q3 2020.

  • SG Americas Securities reported no remaining Serina Therapeutics position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 363 Serina Therapeutics shares in Q3 2020, an estimated $12K.
  • SG Americas Securities first reported a position in Serina Therapeutics in Q4 2018 and held it in 3 quarters.
  • SG Americas Securities's Serina Therapeutics position peaked at $44K in Q1 2019.
  • 36 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.